Hill-Rom Announces CEO Succession Plan (ontinuum and around the world in hospita...)

Hill-Rom Announces CEO Succession Plan

Date:9/17/2009

ontinuum and around the world in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom...enhancing outcomes for patients and their caregivers.

www.hill-rom.com

Disclosure Regarding Forward-Looking Statements

Certain statements in this press release contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections. The Company has tried, wherever possible, to identify these forward-looking statements using words such as "intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate," "strategy," "will," "projection," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower," "reduce," "improve," "expand," "progress," "potential" or the negative of those terms or other variations of them or by comparable terminology. The absence of such terms, however, does not mean that the statement is not forward-looking. It is important to note that forward-looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward-looking statements. Factors that could cause actual results to differ from forward-looking statements include but are not limited to: the Company's dependence on its relationships with several large group purchasing organizations, whether the Company's new products are successful in the marketplace, changes in customers' Medicare reimbursements or other health care reform actions, collections of accounts receivable, compliance with FDA regulations, antitrust litigation, potential exposure to product liability or other cla
'/>"/>

SOURCE Hill-Rom Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4
Related medicine news :

1. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
2. Hill-Rom Announces Singapore Will Be Site for Asia-Pacific Innovation Center
3. Hill-Rom Introduces Fashionable, Affordable Bed for Home and Post-Acute Care Patients
4. Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery
5. Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using Nanotechnology
6. Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket
7. Hill-Rom Holdings, Inc. Announces Completion of Separation of Hillenbrand Industries Creating Two Public Companies
8. Hill-Roms NaviCare(R) WatchChild(R) Solution Provides Enhanced Information Technology Solutions for Obstetrical Care
9. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Second Quarter Earnings Webcast
10. Hill-Rom to Present at the Bank of America 2008 Health Care Conference
11. Hill-Rom to Present at the Citi Healthcare Conference

Post Your Comments:

(Date:12/16/2009)... has been found, , , WEDNESDAY, Dec. 16 (HealthDay News) ... to food poisoning and the stomach pain and diarrhea ... some urinary tract infections. , Researchers have found the ... and restaurants and in women with the infections. ... directly to the women through the food they ate, ...

(Date:12/16/2009)... Age should not be determining factor for use, expert ... people with heart failure are much less likely to ... a new study. , The study included 4,685 people, ... device and had a left ventricular fraction (a measure ... less. , During a three-year period, those who were ...

(Date:12/16/2009)... OrthoAccel Technologies, Inc., developers of the ... device to enhance orthodontics, announced Alison Davies as ... Ms. Davies has spent the last fourteen ... industry, most recently for nine years as a ... of Invisalign . ,, (Logo: ...

(Date:12/16/2009)... Retirement Services Division has announced plans to introduce ... 2010. The new platform will include a full ... in a variety of themes. Plan sponsors will ... of creative options to support the theme best ... RetireSmart participant engagement platform will be phased in ...

(Date:12/16/2009)... diagnostic procedures in cardiology. The idea of publishing an ... of European cardiovascular imagers, is therefore long awaited. The ... with a patient rather than technology-based approach, helping clinicians ... aid of imaging. , The book is divided ... practice of cardiac imaging and its clinical use in ...

Breaking Medicine News(10 mins):Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 2 Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 3 Health News:Implanted Defibrillator Might Extend Life 2 Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2 Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3 Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4 Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 2 Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 3 Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 4 Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 5 Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 2 Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 3

[0] Foodborne E. Coli Suspected in Urinary Tract Infections [0] Implanted Defibrillator Might Extend Life [0] Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom [0] MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform [0] The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center

... earnings per share of $0.89, up 24%- Total revenues ... of $273 million, up 73%- 2009 EPS outlook increased ... Quest Diagnostics Incorporated (NYSE: DGX ), the ... announced that for the first quarter ended March 31, ...

... enhanced RadarFind RTLS , ... Morrisville, NC (PRWEB) April ... healthcare system in North Carolina,s Triangle region, has launched the ... Hospital location. After serving as a development partner since April 2008, ...

... Company Delivers Solid Financial Performance, Continues to Advance ... Corporation (NYSE: SGP ) today reported ... powered through to deliver a solid performance in ... CEO. "We overcame difficult currency comparisons and ...

... pharmaceutical companies find, evaluate and manage drug partners ... drug development lifecycleSAN FRANCISCO, April 21 ... partnering site for the pharmaceutical development and drug ... website, goBalto.com. goBalto transforms the way drug-development partners ...

... DEL MAR, Calif., April 21 Patient Safety Week ... automated blood pressure device (1979), the pulse oximeter (1983) ... personal financial profit. All of these technological devices clearly ... Dr. Barry Friedberg as a forward thinking, caring physician."Until ...

... Surgeons study indicating that 98% of breast cancer patients are satisfied ... surgeon , Dr. Bob Basu explains why breast reconstruction following a ... ... Houston TX (Vocus) April 21, 2009 -- The American Society ...

Quest Diagnostics Reports Strong Earnings Growth In First Quarter 2009 WakeMed Shares Best Practices for Tracking Assets, Patients Schering-Plough Reports Financial Results for 2009 First Quarter Contract Drug Development Resource, goBalto, Launches New Web-Based Platform, goBalto.com American Society of Anesthesiologists Recent Public Debate Comes to Dead End Houston Plastic Surgeon Cites ‘Therapeutic' Benefits for Women that Choose Breast Reconstruction After Mastectomy

(Date:12/16/2009)... 16 Today, Avantium announced the,appointment ... of its pharmaceutical,business. Gunnar Staaf previously worked ... Lilly & Company, in a range of ... important step in Avantium,s plan to,spin-out its ... a,stand-alone pharmaceutical company based on its offering ...

(Date:12/16/2009)... Lower Prescription Drug Prices ,, CHICAGO, Dec. ... night rejected an amendment to the Patient Protection ... prescription drugs more affordable by allowing for the ... from abroad. The bipartisan amendment, endorsed by ... Grassley and Stabenow, would have improved competition and ...

(Date:12/16/2009)... Dec. 16 Frost & Sullivan,s ... looks forward to speaking at the 2010 ... place on January 9, 2010 in Las ... emerging market of consumer-based digital health and ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, Bujnoch focuses ...

Breaking Medicine Technology:Avantium Appoints Gunnar Staaf as CEO Pharma 2 AARP Illinois Key Vote News Alert 2 Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit 2 FDA Approves Lysteda to Treat Heavy Menstrual Bleeding 6264 1 FDA Approves Lysteda to Treat Heavy Menstrual Bleeding 6264 2 Facial Structure May Hold Clues to Aggression 61341 1 Donna H Ryan M D Elected President of The Obesity Society for 2009 2010 61336 1 Donna H Ryan M D Elected President of The Obesity Society for 2009 2010 61336 2 Donna H Ryan M D Elected President of The Obesity Society for 2009 2010 61336 3

[0] Avantium Appoints Gunnar Staaf as CEO Pharma [0] AARP Illinois Key Vote News Alert [0] Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit

... ASCO MeetingINDIANAPOLIS, May 30 Semafore Pharmaceuticals, Inc., ... company, today presented data from a Phase I ... SF1126, at the 2009 American Society of Clinical ... Florida.Dr. E. Gabriela Chiorean, from the Indiana ...

... 29 The American Society of Clinical ... research conducted at the Barbara Ann Karmanos ... ASCO,s Web site. Karmanos, potentially ground-breaking findings ... aggressive hormone receptor negative breast cancer tumors.(Logo: ...

Other Medicine Technology:Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients 2 Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients 3 Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy 2 Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy 3

Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

Medicine Products:

Adenosine Deaminase, RBC ADAMTS13 Activity & Inhibitor (VWF Cleaving Protease)Acyclovir, (Zovirax), Urine Acute Intermittent Porphyria Enzyme

Hill-Rom Announces CEO Succession Plan(ontinuum and around the world in hospita...),Health